The relationship between changes in health behaviour and initiation of lipid-lowering and antihypertensive medications in individuals at high risk of ischaemic heart disease

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Hempler, Nana Folmann ^a   Krasnik, Allan ^a   Pisinger, Charlotta ^b   Jørgensen, Torben ^b,c,d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BLOOD; BLOOD PRESSURE; COHORT ANALYSIS; DENMARK; EXERCISE; FEEDING BEHAVIOR; FEMALE; HEALTH BEHAVIOR; HEART MUSCLE ISCHEMIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; MIDDLE AGED; PHYSIOLOGY; QUESTIONNAIRE; REGISTER; RISK FACTOR;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COHORT STUDIES; DENMARK; EXERCISE; FEMALE; FOOD HABITS; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; QUESTIONNAIRES; REGISTRIES; RISK FACTORS;

EID: 84864571545     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-626     Document Type: Article

References (29)

1. Five-year change in physical activity is associated with changes in cardiovascular disease risk factors: the Inter99 study. Aadahl M, von Huth SL, Pisinger C, Toft UN, Glumer C, Borch-Johnsen K, et al. Prev Med 2009 48 326 331 10.1016/j.ypmed.2009.01.015 19463487
2. Exercise is good for your blood pressure: effects of endurance training and resistance training. Fagard RH, Clin Exp Pharmacol Physiol 2006 33 853 856 10.1111/j.1440-1681.2006.04453.x 16922820
3. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Kodama S, Tanaka S, Saito K, Shu M, Sone Y, Onitake F, et al. Arch Intern Med 2007 167 999 1008 10.1001/archinte. 167.10.999 17533202
4. Effects of the amount and intensity of exercise on plasma lipoproteins. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, et al. N Engl J Med 2002 347 1483 1492 10.1056/NEJMoa020194 12421890
5. Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE-a randomized controlled study. Slentz CA, Duscha BD, Johnson JL, Ketchum K, Aiken LB, Samsa GP, et al. Arch Intern Med 2004 164 31 39 10.1001/archinte.164.1.31 14718319
6. Can dietary interventions change diet and cardiovascular risk factors? A meta-analysis of randomized controlled trials. Brunner E, White I, Thorogood M, Bristow A, Curle D, Marmot M, Am J Public Health 1997 87 1415 1422 10.2105/AJPH.87.9.1415 9314790
7. Dietary advice for reducing cardiovascular risk. Brunner EJ, Rees K, Ward K, Burke M, Thorogood M, Cochrane Database Syst Rev 2007 4 D002128 17943768
8. By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease? Law MR, Morris JK, Eur J Clin Nutr 1998 52 549 556 10.1038/sj.ejcn.1600603 9725654
9. Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. Tang JL, Armitage JM, Lancaster T, Silagy CA, Fowler GH, Neil HA, BMJ 1998 316 1213 1220 9552999
10. Smoking, alcohol consumption, physical activity, and family history and the risks of acute myocardial infarction and unstable angina pectoris: a prospective cohort study. Merry AH, Boer JM, Schouten LJ, Feskens EJ, Verschuren WM, Gorgels AP, et al. BMC Cardiovasc Disord 2011 11 13 10.1186/1471-2261-11-13 21435252
11. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, et al. Lancet 2006 368 647 658 10.1016/S0140-6736(06)69249-0 16920470
12. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Circulation 2002 106 3143 3421 12485966
13. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, et al. Circulation 2004 110 227 239 10.1161/01.CIR.0000133317.49796.0E 15249516
14. Statins for the primary prevention of cardiovascular disease. Taylor F, Ward K, Moore TH, Burke M, Davey SG, Casas JP, et al. Cochrane Database Syst Rev 2011 D004816
15. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. Law MR, Morris JK, Wald NJ, BMJ 2009 338 1665 10.1136/bmj.b1665 19454737
16. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Chiuve SE, McCullough ML, Sacks FM, Rimm EB, Circulation 2006 114 160 167 10.1161/CIRCULATIONAHA.106.621417 16818808
17. Forebyggelse af iskæmisk hjerte-kar-sygdom i almen praksis (Clinical guideline: Prevention of isheaemic heart disease in general practice). Christensen B, Færgemann O, Heebøll-Nielsen, Lous J, Madsen LD, Stender S, Klinisk V, Danish College of General Practitioners 2007
18. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ, BMJ 2006 333 999 10.1136/bmj.38992.565972.7C 17060337
19. Lipid-lowering agents and the risk of hip fracture in a Medicaid population. Ray WA, Daugherty JR, Griffin MR, Inj Prev 2002 8 276 279 10.1136/ip.8.4.276 12460961
20. Statin adherence and risk of accidents: a cautionary tale. Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J, et al. Circulation 2009 119 2051 2057 10.1161/CIRCULATIONAHA.108.824151 19349320
21. A meta-analysis of the association between adherence to drug therapy and mortality. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. BMJ 2006 333 15 10.1136/bmj.38875.675486.55 16790458
22. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, Pisinger C, Eur J Cardiovasc Prev Rehabil 2003 10 377 386 10.1097/01.hjr.0000096541.30533.82 14663300
23. A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials; PRECARD and the Copenhagen Risk Score. Thomsen TF, Davidsen M, Ibsen H, Jorgensen T, Jensen G, Borch-Johnsen K, J Cardiovasc Risk 2001 8 291 297 10.1097/00043798-200110000-00008 11702035
24. Commuting physical activity is favourably associated with biological risk factors for cardiovascular disease. von Huth SL, Borch-Johnsen K, Jorgensen T, Eur J Epidemiol 2007 22 771 779 10.1007/s10654-007-9177-3 17846902
25. Relative validity of a food frequency questionnaire used in the Inter99 study. Toft U, Kristoffersen L, Ladelund S, Bysted A, Jakobsen J, Lau C, et al. Eur J Clin Nutr 2008 62 1038 1046 10.1038/sj.ejcn.1602815 17538538
26. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Brookhart MA, Patrick AR, Dormuth C, Avorn J, Shrank W, Cadarette SM, et al. Am J Epidemiol 2007 166 348 354 10.1093/aje/kwm070 17504779
27. Confounding control in healthcare database research: challenges and potential approaches. Brookhart MA, Sturmer T, Glynn RJ, Rassen J, Schneeweiss S, Med Care 2010 48 114 S120 20473199
28. Are statins really useless in primary prevention? Recent Cochrane meta-analysis revisited. Grammer TB, Maerz W, Int J Clin Pharmacol Ther 2011 49 293 296 21543031
29. The Danish National Prescription Registry. Kildemoes HW, Sorensen HT, Hallas J, Scand J Public Health 2011 39 38 41 10.1177/1403494810394717 21775349